91¾«Æ·ºÚÁϳԹÏ

No image
Dre Mindy Goldman
Professeur auxiliaire, Département de pathologie et de médecine de laboratoire, Faculté de médecine, Université d’Ottawa
Directrice médicale générale, Société canadienne du sang


Numéro de téléphone 
613-739-2577


Biographie

Domaines d’expertise clinique

  • Thrombopénie néonatale allo-immune

  • Réactions indésirables à la transfusion

Domaines d’expertise en médecine de laboratoire

  • ±õ³¾³¾³Ü²Ô´Ç³óé³¾²¹³Ù´Ç±ô´Ç²µ¾±±ð

Publications récentes

  • Traore AN, Delage G, McCombie N, Robillard P, Heddle NM, Hyson C, Goldman M. Clinical and laboratory practices in investigation of suspected transfusion-transmitted bacterial infection: a survey of Canadian hospitals. Vox Sanguinis 2009;96:157-9.
  • OBrien SF, Yi Q-L, Fan W, Fearon MA, Scalia V, Goldman M. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. Transfusion 2009;49:271-7.
  • Goldman M, Xi G, Yi Q-L, Fan W, OBrien SF. Reassessment of deferrals for tattooing and piercing. Transfusion 2009;49:648-54.
  • Ramirez-Arcos S, Goldman M. Skin disinfection methods: Prospective evaluation and post-implementation results. Transfusion 2009. In press.
  • Eder A, Goldman M, Rossmann S, Waxman, Bianco C. Selection Criteria to Protect the Blood Donor in North America and Europe:  Past (Dogma), Present (Evidence), and Future (Hemovigilance). Transfusion Medicine Reviews 2009;23(3):205-20.
  • Bianco C, Eder A, Goldman M. Why do blood centers measure donors blood pressure and pulse? AABB News 2009;11(7):6-7.
  • Eder A, Goldman M, editors. Blood Donor Health and Safety. Bethesda: AABB Press 2009.
  • OBrien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon, MA. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 2008;48:755-61.
  • OBrien SF, Ram SS, Yi QL, Goldman M. Donors understanding of the definition of sex as applied to predonation screening questions. Vox Sanguinis 2008;94:329-33.
  • OBrien SF, Fan W, Xi G, YI QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M, Delage G. Declining hepatitis C rates in first-time blood donors:  insight from surveillance and case-control risk factor studies. Transfusion 2008;48:902-9.
  • Goldman M. Should we attempt to detect bacteria in red blood cells? (editorial). Transfusion 2008;48:1538-40.
  • Pavenski K, Webert KE, Goldman M. Consequences of transfusion of platelet antibody:  a case report and literature review. Transfusion 2008;48:1981-9.
  • OBrien SF, Xi G, Fan W, Yi QL, Fearon MA, Scalia V, Goldman M. Epidemiology of hepatitis B in Canadian blood donors. Transfusion 2008;48:2323-30.

Intérêts de recherche

  • Don de sang
  • Contamination bactérienne des produits sanguins
  • Critères de sélection des donneurs de sang
  • Syndrome respiratoire aigu post-transfusionnel (TRALI)